Literature DB >> 6179732

Drug interferences with clinical laboratory tests.

P P Sher.   

Abstract

The interpretation of clinical laboratory tests is dependent on a host of physiological, environmental and pharmacological factors. At present, it is difficult to determine which of these broad groups is involved when one suspects interference with a clinical laboratory test. Detailed knowledge of the drugs that a patient is consuming is critical in understanding potential interferences. Drugs affect laboratory tests by 2 basic mechanisms: (a) physiological or pharmacological interference, and (b) chemical interference. The major interferences with routine clinical chemistry tests are described in the review which follows. The diversity of therapeutic agents that influence tests, points to the problem of monitoring drug interferences. Awareness of the problem and careful review of drug histories is at present the only realistic method of attempting to minimise the problem. Future use of computer data bases may allow potential drug interferences to be signalled automatically.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179732     DOI: 10.2165/00003495-198224010-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  86 in total

1.  Chemical and diagnostic specificity of laboratory tests. Effect of hemolysis, lipemia, anticoagulants, medications, contaminants, and other variables.

Authors:  W T CARAWAY
Journal:  Am J Clin Pathol       Date:  1962-05       Impact factor: 2.493

2.  A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.

Authors:  L L ABEL; B B LEVY; B B BRODIE; F E KENDALL
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

Review 3.  Chemical interference by drugs and other substances with clinical laboratory test procedures.

Authors:  W T Caraway; C W Kammeyer
Journal:  Clin Chim Acta       Date:  1972-10       Impact factor: 3.786

4.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

5.  Free calcium in serum. II. Rigor of homeostatic control, correlations with total serum calcium, and review of data on patients with disturbed calcium metabolism.

Authors:  J H Ladenson; G N Bowers
Journal:  Clin Chem       Date:  1973-06       Impact factor: 8.327

6.  Sensitivity to dimethyltubocurarine and toxiferine with special reference to serum proteins.

Authors:  J Stovner; L Theodorsen; E Bjelke
Journal:  Br J Anaesth       Date:  1972-04       Impact factor: 9.166

7.  Acute pancreatitis as a complication of Imuran therapy in regional enteritis.

Authors:  J R Nogueira; M A Freedman
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

Review 8.  Uricosuric drugs, with special reference to probenecid and sulfinpyrazone.

Authors:  A B Gutman
Journal:  Adv Pharmacol       Date:  1966

9.  The 2 hour sulfobromophthalein retention test and the transaminase activity during oral contraceptive therapy.

Authors:  U Larsson-Cohn
Journal:  Am J Obstet Gynecol       Date:  1967-05-15       Impact factor: 8.661

10.  Toxicity of indomethacin. Report of a case of acute pancreatitis.

Authors:  M Guerra
Journal:  JAMA       Date:  1967-05-08       Impact factor: 56.272

View more
  1 in total

Review 1.  [Review of the interference between the most commonly prescribed drugs and clinical analyses at the Primary Health Care Centre of L'Hospitalet de Llobregat].

Authors:  R Vargas; N Torné; P Travé; M March; G Rodríguez; S Calero
Journal:  Aten Primaria       Date:  2006-02-28       Impact factor: 1.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.